Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial

Table 3

Comparing lipid profile, hemoglobin, and consumed erythropoietin between two groups.

	Carnitine	Placebo	𝑃
	𝑛=24	𝑛=27
Triglyceride, mg/dL	−31.1±38.7	9.6±32.2	<0.001
Cholesterol, mg/dL	−6.6±16.0	−3.6±24.9	.311
HDL, mg/dL	3.7±2.8	−0.8±3.7	<0.001
LDL, mg/dL	−3.0±10.4	−6.9±24.7	0.239
Hemoglobin, mg/dL	0.7±1.7	0.3±1.4	0.190
Dose of erythropoietin, U/wk	4750±5772	−2000±4296	0.029